The company continues to accuse Oracle
In a recent court filing, Oracle took some pop-culture swings at HP's Itanium strategy: "Intel's independent business judgment would have killed off Itanium years ago. But HP has secretly contracted with Intel to keep churning out Itaniums so that HP can maintain the appearance that a dead microprocessor is still alive. The whole thing is a remake of Weekend at Bernie's."
You don't often see that kind of language in bone-dry legal filings. Some of Oracle's lawyers are clearly enjoying this case. I am not a lawyer, but I can't imagine legal pros being this glib in anything but a slam-dunk, open-and-shut case. Don't expect HP's complaints to gain much traction. In fact, HP seems to be giving up, offering to move Itanium customers to Xeon-powered servers running Microsoft
In related HP news, networking titan Cisco Systems
Everything HP touches doesn't exactly turn into poison and mud, but a series of questionable board-level decisions has left the company often looking silly. Short of a total overhaul of the board and concomitant executive refresh, I don't see the once-mighty tech titan ever returning to its former glory. I've got skin it this game thanks to a big red thumb in Hewlett-Packard in our CAPS system. Follow HP and the rest of my CAPScalls right here.
Fool contributor Anders Bylund holds no position in any of the companies mentioned. The Motley Fool owns shares of Microsoft, Cisco Systems, Intel, and Oracle. The Fool has also bought calls on Intel and created a bull call spread position on Cisco. Motley Fool newsletter services have recommended buying shares of Cisco, Microsoft, and Intel. Furthermore, we have recommended creating bull call spread positions in Intel and Microsoft. Try any of our Foolish newsletter services free for 30 days. We Fools don't all hold the same opinion, but we all believe that considering a diverse range of insights makes us better investors. Check out Anders' holdings and bio, or follow him on Twitter and Google+. We have a disclosure policy.